Laycock Willoughby B. 4

Accession 0000907254-25-000085

CIK 0000907254other

Filed

May 20, 8:00 PM ET

Accepted

May 21, 4:21 PM ET

Size

24.0 KB

Accession

0000907254-25-000085

Form 4

Period: 2025-05-17

DirectorSVP-Res. Design/Mrkt Research

Transactions

Holdings

Common Stock
(indirect: By Spouse)
249.952
Director Stock Option
Exercise: $55.71From: 2019-05-03Exp: 2029-05-03→ Common Stock (2,500 underlying)
2,500
Director Stock Option
Exercise: $47.90From: 2022-05-13Exp: 2032-05-13→ Common Shares (2,500 underlying)
2,500
Director Stock Option
Exercise: $33.79From: 2023-05-12Exp: 2033-05-12→ Common Stock (2,500 underlying)
2,500
Employee Stock Option
Exercise: $55.71From: 2019-05-03Exp: 2029-05-03→ Common Stock (5,000 underlying)
5,000
Employee Stock Option
Exercise: $50.00From: 2020-04-24Exp: 2030-04-24→ Common Stock (10,000 underlying)
10,000
Director Stock Option
Exercise: $43.89From: 2021-05-07Exp: 2031-05-07→ Common Stock (2,500 underlying)
2,500
Director Stock Option
Exercise: $50.00From: 2020-04-24Exp: 2030-04-24→ Common Stock (2,500 underlying)
2,500
Employee Stock Option
Exercise: $43.89From: 2021-05-07Exp: 2031-05-07→ Common Stock (10,000 underlying)
10,000
Employee Stock Option
Exercise: $47.90From: 2022-05-13Exp: 2032-05-13→ Common Stock (10,000 underlying)
10,000
Employee Stock Option
Exercise: $33.79From: 2023-05-12Exp: 2033-05-12→ Common Stock (10,000 underlying)
10,000
Phantom Stock
→ Common Stock (3,934.656 underlying)
3,934.656
Performance Shares
Exercise: $0.00From: 2030-05-09Exp: 2030-05-09→ Common Stock (500 underlying)
500
Performance Shares
Exercise: $0.00From: 2029-05-17Exp: 2029-05-17→ Common Stock (400 underlying)
400

Footnotes (4)

[F1]Shares acquired in an exempt transaction as dividend equivalents on filers restricted stock award, which vested on May 17, 2025.
[F2]The options vest 25% per year over four years from the date of grant.
[F3]New phantom shares are issuable pursuant to the Issuers Deferred Compensation Plan for Directors, as amended and restated effective May 17, 2024 (the Deferred Compensation Plan), under its 2024 Stock Incentive Plan. Phantom shares issued prior to May 17, 2024, continue to be subject to the terms of the Issuers deferred compensation plan for directors in effect prior to the amendment and restatement of the Deferred Compensation Plan.
[F4]The conversion of phantom shares issued on or after May 17, 2024, into shares of the Issuers common stock is governed pursuant to terms of the Issuers Deferred Compensation Plan under its 2024 Stock Plan and the reporting persons Deferred Fee Agreement. The conversion of phantom shares issued prior to May 17, 2024, into shares of the Issuers common stock is governed pursuant to the terms of the Issuers deferred compensation plan for directors in effect prior to the amendment and restatement of the Deferred Compensation Plan and the reporting persons Deferred Fee Agreement.

Documents

1 file

SAUL CENTERS, INC.

CIK 0000907254

Entity typeother